MAPT and Alzheimer disease: Furthermore, hyperphosphorylated species of tau, such as those phosphorylated at threonine 181 (p-tau181), have demonstrated high specificity in distinguishing late-onset Alzheimer’s disease from other neurodegenerative conditions (Janelidze et al., 2020).